Elevated FANCA expression determines a worse prognosis in chronic lymphocytic leukemia and interferes with p53 function-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elevated FANCA expression determines a worse prognosis in chronic lymphocytic leukemia and interferes with p53 function

Published:2019-06-28 Issue:9 Volume:33 Page:10477-10489
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Bravo‐Navas Sara¹,Yáñez Lucrecia¹,Romón Íñigo¹,Pipaón And Carlos¹

Affiliation:

1. Instituto de Investigación Marqués de Valdecilla (IDIVAL)Hospital Marqués de Valdecilla Santander Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201802439RR

Reference35 articles.

1. Chronic lymphocytic leukaemia

2. Predictive and prognostic biomarkers in the era of new targeted therapies for chronic lymphocytic leukemia

3. Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens

4. In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI

5. The role of Bcl-2 family proteins in chronic lymphocytic leukaemia

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4;International Journal of Molecular Sciences;2022-06-10

2. Multicellular biomarkers of drug resistance as promising targets for glioma precision medicine and predictors of patient survival;Cancer Drug Resistance;2022

3. A Different View for an Old Disease: NEDDylation and Other Ubiquitin-Like Post-Translational Modifications in Chronic Lymphocytic Leukemia;Frontiers in Oncology;2021-09-23

4. Fanconi anemia pathway as a prospective target for cancer intervention;Cell & Bioscience;2020-03-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3